Table 2.
Primary tumor | Mesenteric adenopathy | Liver metastases | No uptake | |
---|---|---|---|---|
Localizing (n = 13) | 13 | 3 (23%) | 9 (69%) | NA |
Non-localizing (n = 24) | NA | 10 (42%) | 17 (71%) | 3 (13%) |
p-value | ----- | 0.44 | 1 | ----- |
P-value < 0.05 is considered significant.